Norwegians debut 'compressed' omega-3 tablets


- Last updated on GMT

Norwegians debut 'compressed' omega-3 tablets

Related tags Docosahexaenoic acid Eicosapentaenoic acid

A Norwegian start-up says its patent pending compression technology has allowed it to commercialise omega-3 powder that can be formulated in hard tablets rather than capsules.

After several years development, Omegatri has inked its first deal with Icelandic supplements manufacturer, Lysi, with products set for launch there in September and other countries Lysi sells into.

That product will offer 125mg of omega-3 forms DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) per tablet – half daily recommended EU levels of 250mg per day.

Omegatri chief marketing and sales officer Ludo van de Wiel, who previously worked at DSM-owned Ocean Nutrition Canada, told us the offering targeted the premium end of the market, and would sell above regular fish oil-derived omega-3 capsules, of which he said there were about 15 offered by different parties.

Compression technology

But most of them could not be compressed into a tablet without losing their structural integrity, losing EPA-DHA content and releasing odours, he said.

“We have found a way to convert any oil into powder and make it compressible,” ​he said.

“Otherwise you need an excipient. This technology is quite different and attractive to those in the tablet industry.”

The company exhibited its ingredient and technology for the first time at the recent Vitafoods trade show in Geneva, Switzerland, where interested parties included US and Asian supplement manufacturers, along with contract manufacturers and other omega-3 suppliers including fish and krill oil players.

He said vegetarians that may avoid animal gelatine found in many capsules was another niche market, especially in countries where there are many vegetarians like India and Indonesia.

Van de Wiel, CMSO added: “The omega-3 tablets are well documented through clinical studies at the University Hospital in Oslo. The bioavailability is at least as good as soft gel capsules, the oxidative stability is very robust and no animal gelatine is used. The tablet does not give any fishy burps or after ingestion.”

The company had also received interest from manufacturers of vitamin and multivitamin supplements that saw an opportunity to add marine-sourced omega-3s to their products.

Earlier this year South African firm Dynamic Extractions and Formulations (DEF) said it had developed omega-3 powders that could be used in tablets using an 18-step Dynamic Cellular Disruption (DCD) process.

“With our stablised highly nutritious oil powders the options are greater for producers and manufacturers as the powders can be used in hard gels, tablets or sprinkled over products used in bars, included in shakes and smoothies,”​ the company said at the time​.

Omegatri is owned by PHS based in the Netherlands, GC Rieber and Såkorn Investments in Norway.

Related news

Show more

Related products

show more

Dynamic Duo - More Power, Less Fatigue

Dynamic Duo - More Power, Less Fatigue

Content provided by Enovate Biolife LLC | 27-Jun-2024 | White Paper

Better physical performance & vitality have deep connections to muscular as well as cardio-respiratory health.

Go Beyond Ordinary in Cognitive Health - BacoMind™

Go Beyond Ordinary in Cognitive Health - BacoMind™

Content provided by Natural Remedies Pvt. Ltd. | 26-Jun-2024 | White Paper

BacoMind™, this groundbreaking, clinically proven, and pioneering Bacopa monnieri extract unleashes the power of 9 bioactive compounds to organically boost...

Related suppliers

Follow us


View more